Cell treatment for painful hand sores in systemic sclerosis
Treatments studied
Part of Heart & circulation, Skin clinical trials.
This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of systemic sclerosis (SSc) using 2013 ACR/EULAR criteria
- You have at least one active digital ulcer that is painful, larger than 2 mm, and has visible depth and skin loss
- Your ulcer(s) did not improve with IV prostacyclins (or got worse/returned after treatment)
- X-ray shows the ulcer does not have underlying calcium deposits (calcinosis)
- You can give written consent and are able to come to follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.
This study tests whether a natural supplement called diosmin can help heal finger and toe ulcers in people with scleroderma. If you have a current ulcer that is not infected, you may be able to join.
This study tests an experimental cell therapy that targets your own immune cells to treat systemic sclerosis (scleroderma) with lung involvement. It aims to see if this treatment works better than standard care in reducing disease activity.
This study looks at hand function and disability in people with systemic sclerosis who have digital ulcers. It aims to understand how these ulcers affect daily hand use.
This early-stage trial tests an investigational cell therapy for people with systemic sclerosis (scleroderma). The treatment uses your own modified immune cells to try to calm the overactive immune system and slow the disease, with imaging to see where the cells go in your body.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.